Paroxetine Tablet, Film Coated
Product Images NDC 70518-2465

6 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 70518-2465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 01

9d3352de B6ab 4118 A714 54875d85b0c5 01
Chemical structure of Paroxetine hydrochloride, depicting the molecular arrangement including a fluorophenyl group and a methylenedioxyphenyl moiety linked to a piperidine ring with a hydrochloride component.*
FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 02

9d3352de B6ab 4118 A714 54875d85b0c5 02
A chart depicting fold changes and 90% confidence intervals for the pharmacokinetics (Cmax and AUC) of Paroxetine when interacting with various drugs, including Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis shows change relative to reference on a logarithmic scale from 0.1 to 10.*
FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 03

9d3352de B6ab 4118 A714 54875d85b0c5 03
A forest plot chart showing fold change and 90% confidence intervals of pharmacokinetic parameters Cmax and AUC for Paroxetine when coadministered with various interacting drugs, including Cimetidine 300 mg TID, Phenobarbital 100 mg QD, Phenytoin 300 mg QD, Digoxin 0.25 mg QD, and Diazepam 5 mg TID. The x-axis represents change relative to reference values, ranging from 0 to 2.*
FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 04

9d3352de B6ab 4118 A714 54875d85b0c5 04
A plot showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, Cmin, AUC) of Paroxetine in different population groups, including renal impairment (mild, moderate, severe), hepatic impairment, age over 65 with varying doses, and males. The horizontal axis represents change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Paroxetine 30mg 70518 2465 01

Paroxetine 30mg 70518 2465 01
Paroxetine 30 mg film-coated tablets packaging label showing a quantity of 90 tablets. The label includes the product name PARoxetine, dosage strength 30 mg, and specifies the form as tablets. It is repackaged by RemedyRepack Inc. with directions to see the package insert, storage instructions at 20-25°C, and manufacturer information listing Zydus Pharm, Pennington, NJ.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Paroxetine 30 mg film-coated tablets packaging label showing quantity of 30 tablets. The label indicates the product is repackaged by RemedyRepack Inc. and manufactured by Zydus Pharm, Pennington, NJ. It includes storage directions, a QR code, and cautions to keep medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.